Comerica Bank Pfizer Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Pfizer Inc stock. As of the latest transaction made, Comerica Bank holds 2,007,898 shares of PFE stock, worth $50.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

2,007,898

Previous 2,027,833 0.98%

Holding current value

$50.1 Million

Previous $56.7 Million 2.41%

% of portfolio

0.23%

Previous 0.24%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $552,199 - $625,759	-19,935 Reduced 0.98%	2,007,898 $58.1 Million
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $1.15 Million - $1.35 Million	45,456 Added 2.29%	2,027,833 $56.7 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $665,502 - $764,209	-25,705 Reduced 1.28%	1,982,377 $55 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $2.68 Million - $3.48 Million	-102,459 Reduced 4.85%	2,008,082 $57.8 Million
Q3 2023 Nov 21, 2023	BUY	$32.09 - $37.51 $20.2 Million - $23.7 Million	630,708 Added 42.62%	2,110,541 $70 Million
Q2 2023 Aug 22, 2023	BUY	$36.12 - $41.79 $4.35 Million - $5.03 Million	120,351 Added 8.85%	1,479,833 $740,000
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $382,137 - $498,838	9,153 Added 0.68%	1,359,482 $0
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $784,310 - $957,446	17,923 Added 1.35%	1,350,329 $61.5 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $1.93 Million - $2.29 Million	-41,556 Reduced 3.02%	1,332,406 $68.4 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $170,235 - $210,943	-3,721 Reduced 0.27%	1,373,962 $71.1 Million
Q4 2021 Feb 18, 2022	SELL	$41.32 - $61.25 $2 Million - $2.97 Million	-48,458 Reduced 3.4%	1,377,683 $81.4 Million
Q3 2021 Nov 22, 2021	SELL	$39.25 - $50.42 $11.6 Million - $15 Million	-296,809 Reduced 17.23%	1,426,141 $61.3 Million
Q2 2021 Aug 26, 2021	SELL	$35.91 - $40.68 $1.17 Million - $1.33 Million	-32,686 Reduced 1.86%	1,722,950 $67.5 Million
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $755,902 - $852,506	-22,571 Reduced 1.27%	1,755,636 $63.6 Million
Q4 2020 Jan 28, 2021	SELL	$33.47 - $42.56 $1.34 Million - $1.7 Million	-39,895 Reduced 2.19%	1,778,207 $65.5 Million
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $231,584 - $271,701	-7,294 Reduced 0.4%	1,818,102 $63.3 Million
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $1.72 Million - $2.09 Million	57,240 Added 3.24%	1,825,396 $56.6 Million
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $145,475 - $207,852	5,382 Added 0.31%	1,768,156 $54.8 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $1.48 Million - $1.68 Million	-44,961 Reduced 2.49%	1,762,774 $65.5 Million
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $395,435 - $512,764	12,171 Added 0.68%	1,807,735 $61.6 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $3.18 Million - $3.57 Million	-85,867 Reduced 4.56%	1,795,564 $0
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $6.05 Million - $6.65 Million	-161,463 Reduced 7.9%	1,881,431 $0
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $3.4 Million - $3.88 Million	-88,450 Reduced 4.15%	2,042,894 $83.3 Million
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $11.5 Million - $13.9 Million	-332,452 Reduced 13.49%	2,131,344 $94 Million
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $2.51 Million - $2.67 Million	-76,016 Reduced 2.99%	2,463,796 $92.8 Million
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $1.24 Million - $1.44 Million	-38,940 Reduced 1.51%	2,539,812 $92.8 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $1.64 Million - $1.73 Million	-49,163 Reduced 1.87%	2,578,752 $95.2 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $81.5 Million - $89.7 Million	2,627,915	2,627,915 $92.4 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account